| QLINEA Stock | | | SEK 0.72 0.03 4.35% |
CEO
Mr. Jonas Jarvius was Chief Executive Officer at QLinea AB since 2008. He has RD experience in the field of molecular medicine and molecular biological detection. He has cofounded several companies and is one of the founders of Qlinea. For many years, he has also held senior positions in various biotech companies and in these roles, has managed projects related to molecular detection for safety applications and the manufacture and development of medical devices. He also has experience in ISO 13485 certification, a quality management standard for medical devices. In addition, he was involved in several biotech startups. He holds PhD in molecular medicine, Uppsala University MSc in medical science, Uppsala University . Jonas Jarvius is chairman of the board of Umbrella Science AB and a member of the board of directors of QuiaPEG Pharmaceuticals Holding AB . since 2008.
| Age | 52 |
| Tenure | 17 years |
| Phone | 46 1 84 44 36 10 |
| Web | https://www.qlinea.com |
Q Linea Management Efficiency
The company has return on total asset
(ROA) of
(0.3953) % which means that it has lost $0.3953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.7175) %, meaning that it generated substantial loss on money invested by shareholders. Q Linea's management efficiency ratios could be used to measure how well Q Linea manages its routine affairs as well as how well it operates its assets and liabilities.
Q-linea AB researches, develops, manufactures, and sells instruments and disposables for infection diagnostics. Q-linea AB was founded in 2008 and is based in Uppsala, Sweden. Q Linea operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 61 people. Q linea AB (QLINEA) is traded on Stockholm Exchange in Sweden and employs 156 people.
Management Performance
Q linea AB Leadership Team
Elected by the shareholders, the Q Linea's board of directors comprises two types of representatives: Q Linea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QLINEA. The board's role is to monitor Q Linea's management team and ensure that shareholders' interests are well served. Q Linea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Q Linea's outside directors are responsible for providing unbiased perspectives on the board's policies.
QLINEA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Q Linea a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Other Information on Investing in QLINEA Stock
Q Linea financial ratios help investors to determine whether QLINEA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in QLINEA with respect to the benefits of owning Q Linea security.